Public Health — SureAdhere

SureAdhere for Public Health

Scale patient engagement efforts through live and asynchronous video observed therapy and improve treatment outcomes through immediate follow-up with patients most in need.

SureAdhere has been clinically validated by the US Centers for Disease Control and Prevention to provide equivalent treatment outcomes to in-person directly observed therapy (DOT), without the burden or expense.

REQUEST A DEMO

Drug-by-drug Medication Support

Detailed dosing histories combined with escalation task lists, support action logging, and side-effect tracking complete a comprehensive treatment record at every dose. Virtual care tools like two-way SMS chat and live virtual visits enable real-time feedback when patients need additional support.

Scaled Program Capacity

Focus staff resources on individuals most in need while increasing the total number of medication doses observed, saving program administration costs, and reducing dependence on paper and manual record keeping.

High Accessibility

The offline-first approach enables patients to progress through treatment at their own pace and extends access to remote support for individuals living in areas with low connectivity.
Simple app design available in multiple languages supports patients with varying language, literacy, and technical ability.

Globally Recognised

Over 350 Public Health programs across the US, Europe & Asia use SureAdhere. SureAdhere complies with US HIPAA and European GDPR data privacy regulations, and our global support team provides comprehensive service level agreements based on local time zones.

Talk to us to learn how we can support your region-specific requirements >

SureAdhere for TB Treatment

From 2018 to 2021, the US Centers for Disease Control and Prevention (CDC) and the New York City Department of Mental Health and Hygiene (NYC Health) conducted a randomized controlled trial (RCT) comparing eDOT to in-person DOT using the SureAdhere VOT platform for recorded eDOT. The trial, published in JAMA Open Network, demonstrated that eDOT was clinically non-inferior to in-person DOT, and reduced TB treatment burden for both patients and providers.

These trial results, along with the comprehensive VOT evidence base, informed the World Health Organization's (WHO) 2022 TB treatment guidelines. WHO’s guidelines now state that "video observed therapy may replace in-person DOT where video communication technology is available." This study also supported the CDC in updating agency TB treatment guidelines in 2023, recommending VOT as “an equivalent alternative to in-person DOT”. This milestone has allowed US health departments to widely adopt VOT as the standard of care for TB treatment in their programs.

Additional Public Health Use

HIV Treatment & Prevention

SureAdhere's self-administered dose capture functionality, along with ongoing treatment support through virtual communications, has the potential to enhance long-term health for people living with HIV and those using PrEP by helping them maintain a consistent routine, particularly during the crucial initial phase.

Real time-time data tracking with VDOT leads to better disease management and empowers patients to gain greater control over their health. Healthcare providers can effectively support and monitor patients, ensuring they receive the full benefits of DOT.

Learn More

Hepatitis C

Chronic hepatitis C stands as the primary cause for liver transplants in the US (CDC 2016). To prevent delayed recovery and drug resistance caused by non-adherence to daily oral medications, we assist patients in establishing a daily medication routine. Moreover, our platform enables health professionals to effortlessly monitor Hepatitis C treatment adherence, ensuring optimal outcomes for patients.

According to recent clinical studies, the treatment time for Hepatitis C can now be reduced to around 3 months, with a remarkable 95% effectiveness..

Learn More

Our Partners in Public Health

"The SureAdhere app has been an absolute lifesaver for our local health department. The transition to VDOT with SureAdhere has saved us valuable time and resources. The implementation was seamless, and the customer support has been fantastic. Our patients love the app and appreciate the freedom it gives them to take their medications on their own schedule. We've been using SureAdhere as our DOT partner for several years now, and it has exceeded our expectations. It has significantly reduced travel time and costs for our staff, allowing them to focus on other important tasks while ensuring our patients adhere to their medication regimen. We highly recommend SureAdhere in need of a reliable VDOT solution."

Williamson County and Cities Health District
"SureAdhere has increased patient satisfaction, is easy to use, and securely documents patient doses."

A local health department in Washington State.
"SureAhere has made it easier for our patients to take their medication at times that are more convenient for them. It has allowed our patient to have more of a “normal day”, whether it’s because of work/school or side effects of medications. As outreach workers, SureAdhere has reduced the time we spend on the road for Direct Observed Therapy. We can now ensure our patients' adherence to treatment while also monitoring their needs and providing necessary support."

Denver Health and Hospital Authority